FI117001B - Menetelmä psoriasiksen hoitoon tehokas olevan farmaseuttisen seoksen valmistamiseksi - Google Patents

Menetelmä psoriasiksen hoitoon tehokas olevan farmaseuttisen seoksen valmistamiseksi Download PDF

Info

Publication number
FI117001B
FI117001B FI962506A FI962506A FI117001B FI 117001 B FI117001 B FI 117001B FI 962506 A FI962506 A FI 962506A FI 962506 A FI962506 A FI 962506A FI 117001 B FI117001 B FI 117001B
Authority
FI
Finland
Prior art keywords
approx
salicylic acid
mixture
cream
mometasone furoate
Prior art date
Application number
FI962506A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI962506L (fi
FI962506A0 (fi
Inventor
Joel A Sequeira
Imtiaz A Chaudry
Edwin A Peets
Daniel J Tanner
Eugene L Taylor
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI962506L publication Critical patent/FI962506L/fi
Publication of FI962506A0 publication Critical patent/FI962506A0/fi
Application granted granted Critical
Publication of FI117001B publication Critical patent/FI117001B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI962506A 1993-12-21 1996-06-17 Menetelmä psoriasiksen hoitoon tehokas olevan farmaseuttisen seoksen valmistamiseksi FI117001B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US17105193A 1993-12-21 1993-12-21
US17105193 1993-12-21
PCT/US1994/014165 WO1995017196A1 (en) 1993-12-21 1994-12-19 Psoriasis treatment
US9414165 1994-12-19

Publications (3)

Publication Number Publication Date
FI962506L FI962506L (fi) 1996-06-17
FI962506A0 FI962506A0 (fi) 1996-06-17
FI117001B true FI117001B (fi) 2006-05-15

Family

ID=22622295

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962506A FI117001B (fi) 1993-12-21 1996-06-17 Menetelmä psoriasiksen hoitoon tehokas olevan farmaseuttisen seoksen valmistamiseksi

Country Status (21)

Country Link
EP (1) EP0735885B1 (cs)
JP (2) JP3830963B2 (cs)
KR (1) KR100361240B1 (cs)
CN (1) CN1055392C (cs)
AT (1) ATE271896T1 (cs)
AU (1) AU701833B2 (cs)
CA (1) CA2179628C (cs)
CZ (1) CZ283932B6 (cs)
DE (1) DE69433923T2 (cs)
ES (1) ES2221928T3 (cs)
FI (1) FI117001B (cs)
HU (1) HU226621B1 (cs)
IL (1) IL112019A (cs)
MY (1) MY111719A (cs)
NO (1) NO310854B1 (cs)
NZ (1) NZ278198A (cs)
PL (1) PL178427B1 (cs)
SK (1) SK280766B6 (cs)
TW (1) TW442281B (cs)
WO (1) WO1995017196A1 (cs)
ZA (1) ZA9410143B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19736265C2 (de) * 1997-08-15 2002-10-31 Phytexpert Pharm Tox Consultin Arzneimittel zur Behandlung von Hauterkrankungen
JP4101464B2 (ja) * 1998-08-26 2008-06-18 塩野義製薬株式会社 抗炎症軟膏剤
GR1006093B (el) * 2007-09-07 2008-10-06 Γεωργιος Καλλιμανης Παρασκευη φαρμακου με δραστικο συστατικο ουρσολικο οξυ (ursolic acid) για την θεραπεια ψωριασης
NZ591093A (en) * 2008-10-30 2012-02-24 Ego Pharmaceuticals Pty Ltd Anti-inflammatory pharmaceutical compositions comprising a corticosteroid, hexylene glycol and water
EP2394653A1 (en) 2010-05-26 2011-12-14 Almirall, S.A. Topical pharmaceutical compositions comprising mometasone furoate
CN114159453A (zh) * 2021-12-24 2022-03-11 广西馨海药业科技有限公司 白头翁皂苷b4在制备治疗或预防银屑病的药物的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4579844A (en) * 1976-05-13 1986-04-01 Johnson & Johnson Topical anti-inflammatory drug therapy
DE2744826A1 (de) * 1976-10-06 1978-04-13 Marques Brev Soc Et Exploit Therapeutische zubereitung
CY1359A (en) * 1981-02-02 1987-08-07 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
YU46838B (sh) * 1986-02-14 1994-06-24 Pero Dr. Višnjić Postupak za dobijanje preparata za lečenje kožne bolesti psoriazisa
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
US5061700A (en) * 1989-11-16 1991-10-29 Gordon Jay Dow Glyceryl acetate ointment vehicles

Also Published As

Publication number Publication date
NO962619L (no) 1996-06-20
JP3830963B2 (ja) 2006-10-11
AU1432895A (en) 1995-07-10
EP0735885B1 (en) 2004-07-28
DE69433923T2 (de) 2005-07-21
HU9601708D0 (en) 1996-08-28
PL315150A1 (en) 1996-10-14
MY111719A (en) 2000-11-30
ES2221928T3 (es) 2005-01-16
NO962619D0 (no) 1996-06-20
FI962506L (fi) 1996-06-17
WO1995017196A1 (en) 1995-06-29
CN1055392C (zh) 2000-08-16
CN1138294A (zh) 1996-12-18
HUT74460A (en) 1996-12-30
CZ178496A3 (en) 1997-04-16
SK280766B6 (sk) 2000-07-11
ATE271896T1 (de) 2004-08-15
JPH09506897A (ja) 1997-07-08
HU226621B1 (en) 2009-04-28
TW442281B (en) 2001-06-23
FI962506A0 (fi) 1996-06-17
HK1008814A1 (en) 1999-05-21
NO310854B1 (no) 2001-09-10
CA2179628A1 (en) 1995-06-29
JP2005139210A (ja) 2005-06-02
KR100361240B1 (ko) 2003-01-29
CA2179628C (en) 2000-10-24
IL112019A (en) 2000-02-17
KR960706345A (ko) 1996-12-09
AU701833B2 (en) 1999-02-04
CZ283932B6 (cs) 1998-07-15
IL112019A0 (en) 1995-03-15
NZ278198A (en) 1997-12-19
EP0735885A1 (en) 1996-10-09
SK81896A3 (en) 1997-04-09
DE69433923D1 (de) 2004-09-02
ZA9410143B (en) 1995-06-20
PL178427B1 (pl) 2000-04-28

Similar Documents

Publication Publication Date Title
EP4512472A2 (en) Topical formulations comprising cannabidiol, method of preparing the composition and use thereof
CA2301009C (en) Skin care compositions and use
KR100775803B1 (ko) 유효 성분으로서 보효소 ｑ 를 함유하는 피부용 조성물
JP2003533491A (ja) 薬学的及び／又は美容的組成物
JPS6330884B2 (cs)
CN108853312A (zh) 聚桂醇外用凝胶及其制备方法
JP2693859B2 (ja) 尋常性▲ざ▼瘡用皮膚外用剤
FI117001B (fi) Menetelmä psoriasiksen hoitoon tehokas olevan farmaseuttisen seoksen valmistamiseksi
JP2000095683A (ja) 皮膚外用剤
RU2097032C1 (ru) Фармацевтический препарат в форме крема
US20050152993A1 (en) Composition for and method of treatment for skin ailments
JPH03227921A (ja) ケロイド治療剤
JPS6333326A (ja) 抗菌剤組成物
US6077865A (en) Topical antifungal formulation containing tolnaftate
EP1647282A1 (en) Topical anti-inflammatory aqueous gel containing menthol, thymol and eucalyptol, process for their preparation and use of thereof
JP2640492B2 (ja) 皮膚外用剤
JPH01290613A (ja) 皮膚疾患治療剤および化粧品
JPH01294635A (ja) 局所投与用製薬組成物
JPH0782162A (ja) 皮膚外用剤
HK1008814B (en) Ointments comprising mometasone furoate and salicylic acid for the topical treatment of psoriasis
BG65352B1 (bg) Средство за лечение на псориазис
JPH0529008B2 (cs)
JPH0725773A (ja) 鎮痛クリーム

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117001

Country of ref document: FI

PC Transfer of assignment of patent

Owner name: MERCK SHARP & DOHME CORP.

MA Patent expired